De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Tibet AIM Pharm Balans Gezondheid
Financiële gezondheid criteriumcontroles 6/6
Tibet AIM Pharm has a total shareholder equity of CN¥736.2M and total debt of CN¥11.0M, which brings its debt-to-equity ratio to 1.5%. Its total assets and total liabilities are CN¥923.7M and CN¥187.6M respectively. Tibet AIM Pharm's EBIT is CN¥23.6M making its interest coverage ratio -5.5. It has cash and short-term investments of CN¥324.2M.
Belangrijke informatie
1.5%
Verhouding schuld/eigen vermogen
CN¥11.00m
Schuld
| Rente dekkingsratio | -5.5x |
| Contant | CN¥324.18m |
| Aandelen | CN¥736.17m |
| Totaal verplichtingen | CN¥187.57m |
| Totaal activa | CN¥923.75m |
Recente financiële gezondheidsupdates
Geen updates
Analyse van de financiële positie
Kortlopende schulden: 002826's short term assets (CN¥490.0M) exceed its short term liabilities (CN¥181.4M).
Langlopende schulden: 002826's short term assets (CN¥490.0M) exceed its long term liabilities (CN¥6.2M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: 002826 has more cash than its total debt.
Schuld verminderen: 002826's debt to equity ratio has reduced from 11.2% to 1.5% over the past 5 years.
Schuldendekking: 002826's debt is well covered by operating cash flow (1226.8%).
Rentedekking: 002826 earns more interest than it pays, so coverage of interest payments is not a concern.